What this instrument covers

The Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 is a federal legislative instrument that sets out Australia's national scheduling rules for poisons, medicines, and controlled drugs. The full text is available at https://www.legislation.gov.au/F2026L00633.

Scheduling framework

The instrument classifies substances into schedules ranging from Schedule 2 pharmacy medicines through to Schedule 10 prohibited substances. Alongside scheduling, the instrument sets rules covering:

Dates this instrument applies

The instrument came into force on 28 May 2026. It applies until 30 September 2026, when it is repealed and replaced by the Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026.

Transitional provisions

Transitional provisions for the repeal are set out in subsections 4(2) and 4(3) of the successor instrument, the Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026.

Key actions stated in this instrument

This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.